SEARCH RESULT

Total Matching Records found : 59

The dark underbelly of India’s clinical trials business-Malia Politzer and Vidya Krishnan

-Live Mint Incidents at Bhopal and Indore highlight irregularities and ethical violations in some trials In 2004, doctors at the Bhopal Memorial Hospital and Research Centre (BMHRC), established exclusively for treating the victims of the 1984 gas leak, recruited unsuspecting survivors for clinical trials without their knowledge or consent; 14 participants died during the course of the trials. Together with the episode in Indore’s Maharaja Yashwantrao Hospital (that Mint reported on 10...

More »

Herbal oil ads: Govinda tells FDA he was unaware of laws

-Mid Day Last month, the Food and Drug Administration (FDA) had filed 67 complaints at police stations across the state under various sections of the Drugs and Magic Remedies (Objectionable advertisements) Act, 1955. These include complaints against advertisements of products such as 'Sandhi Sudha plus', 'Step up herbal oil' and 'Power Prash', which are promoted by leading Bollywood stars. The FDA had lodged complaints, demanding action against the drug manufacturers, scriptwriters and...

More »

Maize should not be included in PDS-Tejinder Narang

The proposed National Food Security Bill (NFSB), under consideration of Standing Committee of Parliament, may be reviewed for procurement and distribution of maize or corn (under coarse grains scheme) at Rs 1 per kg to intended beneficiaries. Without going into the merits and demerits of ever-increasing subsidies under NFSB, corn for human consumption is highly vulnerable to impermissible limits of fungal toxicity — called “aflatoxins (B1, B2, G1, G2)”. There are...

More »

Protests in US over high pricing of Novartis' anti-cancer drug Glivec-Divya Rajagopal

Health activists and cancer patients in the US have pounced on Swiss drug multinational Novartis for the high price of its famous, multi-billion dollar anti-cancer drug Glivec, a development which challenges pharma MNCs' claims of cheap access and affordability for patented drugs. Such protests, which began first in Europe, and have now spread to the US, could make it more difficult for pharma MNCs in developing countries to convince sceptical governments...

More »

Shamnad Basheer, Intellectual Property Law Professor at NUJS interviewed by V Venkatesan

PROFESSOR Shamnad Basheer joined the National University of Juridical Sciences (NUJS), Kolkata, in November 2008 as the first Ministry of Human Resource Development Chaired Professor in Intellectual Property Law. Before this, he was Frank H. Marks Visiting Associate Professor of Intellectual Property Law at the George Washington University law school and a research associate at the Oxford Intellectual Property Research Centre (OIPRC).  He is the founder of several initiatives, including...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close